Manifold Bio is a pioneering biotech company dedicated to advancing the field of protein therapeutics through cutting-edge molecular measurement technologies and innovative library-guided protein engineering. The company distinguishes itself with a robust drug discovery engine that employs massively parallel in vivo screening from the very beginning, supported by its proprietary protein barcoding technology. This allows for multiplexed protein quantitation at an unprecedented scale and sensitivity, setting new standards in the industry. By seamlessly integrating high-throughput protein engineering techniques with computational design, Manifold Bio is able to develop antibody-like drugs and other biologics that precisely target therapeutic opportunities, addressing significant clinical challenges. The company is also deeply committed to cultivating a diverse and talented workforce, recognizing that varied experiences and perspectives are essential in building effective teams that drive impactful solutions in healthcare.